Predictors of Clinical Course and Treatment Response in DBT Programmes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-70
SponsorOslo University Hospital

About this trial

The project is a collaboration between The National Centre for Suicide Research and Prevention (NSSF) and clinical units with Dialectical Behaviour Therapy (DBT) programmes. A methodological and technological platform has been established that enables clinicians to deliver high quality treatments over extended periods of time, to evaluate their own performance and productivity and to report it in a uniform and systematic way that will enable comparison across clinical settings and programmes. The collected data constitute the basis for conducting the clinical study with the overall aim to study predictors of the clinical course and treatment response in patients admitted to DBT programmes in Norway.

Eligibility criteria

Qualifiers

History of repeated deliberate self harm

Satisfies criteria of Diagnostic and Statistical Manual (DSM-IV) Borderline Personality Disorder as measured by Structured Clinical Interview for the DSM (SCID-II) in addition to the self-destructive criterion.

Disqualifiers

Psychotic disorders

Anorexia Nervosa

Substance dependence disorder

Mental retardation (IQ less than 70)

Trial design

Treatments tested in this trial

  • Dialectical Behaviour Therapy adapted for adolescents (DBT-A)
  • Dialectical Behaviour Therapy - Standard version (DBT)

Treatment groups

250 Participants
are divided into 1 treatment group

Sponsors and collaborators

Oslo University Hospital

Lead sponsor

Vestre Viken Hospital Trust

Collaborator

St. Olavs Hospital

Collaborator

Sykehuset Ostfold

Collaborator

University of Oslo

Collaborator

Nordlandssykehuset HF

Collaborator